Preparation and evaluation of in situ gelling ophthalmic drug delivery system for methazolamide

Drug Development and Industrial Pharmacy

Volumn 36, Issue 11, 2010, Pages 1340-1347

  Qian, Yong ^a   Wang, Fengzhen ^a   Li, Rui ^a   Zhang, Qing ^a   Xu, Qunwei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Carbonic anhydrase inhibitors; Glaucoma; In situ gelling; Methazolamide; Ocular pharmacokinetics; Ophthalmic delivery system

Indexed keywords

BRINZOLAMIDE; METHAZOLAMIDE; POLOXAMER;

ANIMAL EXPERIMENT; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG ELIMINATION; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG SYNTHESIS; EXPERIMENTAL RABBIT; FEMALE; GELATION; IN VITRO STUDY; IN VIVO STUDY; INTRAOCULAR PRESSURE; MALE; NONHUMAN;

ANIMALS; AQUEOUS HUMOR; BIOLOGICAL AVAILABILITY; CARBONIC ANHYDRASE INHIBITORS; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; EYE; FEMALE; GELS; INTRAOCULAR PRESSURE; MALE; METHAZOLAMIDE; POLOXAMER; RABBITS; TEMPERATURE; TIME FACTORS;

EID: 77956929706     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639041003801893     Document Type: Article

References (25)

1. Becker B. (1954). Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, diamox; a preliminary report. Am J Ophthalmol, 37:13-15
2. El-Gazayerly ON, Hikal AH. (1997). Preparation and evaluation of acetazolamide liposomes as an ocular delivery system. Int J Pharm, 158:121-127
3. Zimmerman TJ. (1978). Acetazolamide and methazolamide. Ann Ophthalmol, 10:509-510
4. Angela CP. (1990). Stable ophthalmic composition comprising methazolamide. UK patent no.2223166 A.
5. Hurvitz LM, Kaufman PL, Robin AL, Weinreb RN, Crawford K, Shaw B. (1991). New developments in the drug treatment of glaucoma. Drugs, 41:514-532
6. Fridriksdóttir H, Loftsson T, Stefánsson E. (1997). Formulation and testing of methazolamide cyclodextrin eye drop solutions. J Control Release, 44:95-99
7. Srividya B, Cardoza RM, Amin PD. (2001). Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Release, 73:205-211
8. Kaur IP, Garg A, Singla AK, Aggarwal D. (2004). Vesicular systems in ocular delivery: An overview. Int J Pharm, 269:1-14.
9. Middletion DL, Leung SS, Robinson JR. (1990). Ocular bioadhhesive delivery systems. In: Lenaerts V, Gurny R, eds. Bioadhesive drug delivery systems. Boca Raton, FL: CRC Press, 179-202.
10. Qi HY, Chen WW, Huang CT, Li L, Chen CM, Li WM, et al. (2007). Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int J Pharm, 337:178-187
11. Liu ZD, Li JW, Nie SF, Liu H, Ding PT, Pan WS. (2006). Study of alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin. Int J Pharm, 315:12-17
12. Mansour M, Mansour S, Mortada ND, Abd Elhady SS. (2008). Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels. Drug Dev Ind Pharm, 34:744-752
13. Mayol L, Quaglia F, Borzacchiello A, Ambrosio L, Rotonda MIL. (2008). A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: Rheological, mucoadhesive and in vitro release properties. Eur J Pharm Biopharm, 70:199-206.
14. Wei G, Xu H, Ding PT, Li SM, Zheng JM. (2002). Thermosetting gels with modulated gelation temperature for ophthalmic use: The rheological and gamma scintigraphic studies. J Control Release, 83:65-74.
15. Gilbert JC, Richardson JL, Martyn CD, Palin KJ. (1987). The effect of solutes and polymers on the gelation properties of pluronic-F127 solutions for controlled drug delivery. J Control Release, 5:113-118
16. Kim EY, Gao ZG, Park JS, Li H, Han K. (2002). rhEGF/HP-b-CD complex in poloxamer gel for ophthalmic delivery. Int J Pharm, 233:159-167
17. Chen E, Chen J, Cao SL, Zhang QZ, Jiang XG. (2010). Preparation of nasal temperature-sensitive in situ gel of Radix Bupleuri and evaluation of the febrile response mechanism. Drug Dev Ind Pharm, 36:490-496
18. Liu Z, Yang XG, Li X, Pan W, Li J. (2007). Study on the ocular pharmacokinetics of ion-activated in situ gelling ophthalmic delivery system for gatifloxacin by microdialysis. Drug Dev Ind Pharm, 33:1327-1331
19. Lederer CM Jr, Harold RE. (1986). Drop size of commercial glaucoma medications. Am J Ophthalmol, 101:691-694
20. Hagerstrom H, Paulsson M, Edsman K. (2000). Evaluation of mucoadhesion for two polyelectrolyte gels in simulated physiological conditions using a rheological method. Eur J Pharm Sci, 9:301-309
21. Choi HG, Jung JH, Ryu JM, Yoon SJ, Oh YK, Kim CK. (1998). Development of in situ-gelling and mucoadhesive acetaminophen liquid suppository. Int J Pharm, 165:33-44.
22. Vadnere M, Amidon G, Lindenbaum S, Haslam JL. (1984). Thermodynamic studies on the gel-sol transition of some pluronic polyols. Int J Pharm, 22:207-218
23. Wu CJ, Qi HY, Chen WW, Huang CY, Su C, Li WM, et al. (2007). Preparation and evaluation of a carbopol®/HPMC-based in situ gelling ophthalmic system for puerarin. Yakugaku Zasshi, 127:183-191
24. Edsman K, Carlfors J, Petersson R. (1998). Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur J Pharm Sci, 6:105-112 (Pubitemid 28164280)
25. Lin HR, Sung KC. (2000). Carbopol/pluronic phase change solutions for ophthalmic drug delivery. J Control Release, 69:379-388